629 search results for “bart cancer” in the Staff website
-
Bart Mertens -
Bart Bulsing
Service Unit Real Estate
-
Bart HoenenLURIS
-
Bart Stastny
Faculty of Humanities
-
Bart Gorissen
Faculty of Law
-
Bart Gorissen
Faculteit der Rechtsgeleerdheid
-
Bart Wentholt
Leiden University Libraries
-
Bart AlewijnseFaculty of Humanities
-
Bart VogelaarFaculty of Social and Behavioural Sciences
-
Bart Lenselink -
Bart ZantvoortFaculty of Humanities
-
Bart Wielders
Faculteit Governance and Global Affairs
-
Bart van Hoek -
Bart SchreudersFaculteit der Rechtsgeleerdheid
-
Bart Roep -
Bart SchermerFaculteit der Rechtsgeleerdheid
-
Bart JoosenFaculteit der Rechtsgeleerdheid
-
Bart Collard
Faculteit der Rechtsgeleerdheid
-
Bart LabuschagneFaculteit der Rechtsgeleerdheid
-
Bart de Vries
Faculty of Social and Behavioural Sciences
-
Bart de Jongh
Social & Behavioural Sciences
-
Bart Verkuil
Faculty of Social and Behavioural Sciences
-
Bart SchuurmanFaculteit Governance and Global Affairs
-
Bart VerheijenFaculty of Humanities
-
Bart CustersFaculteit der Rechtsgeleerdheid
-
Bart Monsma-Hempel -
Bart BarendregtFaculty of Social and Behavioural Sciences
-
Bart KransFaculteit der Rechtsgeleerdheid
-
Bart de Leeuw
Faculty of Humanities
-
Bart van der Wal
-
Bart de Smit -
Bart van Lieshout -
Bart van Strien -
Bart van der BoomFaculty of Humanities
-
Bart van der SteenLeiden University Libraries
-
Jan-Bart GewaldAfrika-Studiecentrum
- Kiki Zanolie and Bart Vogelaar: "Let students experience what extra challenge can do"
-
Video lecture: What is cancer?
Cancer is still one of the most common diseases in the world. What exactly is cancer and will we one day be able to cure everyone? In a video from the Universiteit van Nederland Noel de Miranda (Tumour Immunology, LUMC) tells you about his research on new treatments.
-
‘Genetic variants could help determine whether breast cancer is hereditary’
We already know a lot about genetics and the risk of breast cancer. But much still needs to be done in breast cancer genetics to improve the prognosis and make sure women at high risk aren’t missed. This is what Professor by Special Appointment Marjanka Schmidt will say in her inaugural lecture on 4…
-
Breast cancer risk more accurate after genetic test
Leiden University Medical Center (LUMC) has spent the past five years coordinating an international study of genetic mutations and breast cancer risks. The results will make it easier to determine which genes increase the risk of breast cancer and to what extent. The researchers published their results…
-
Sebastian Pomplun joins Oncode Institute to accelerate breakthroughs in cancer research
Sebastian Pomplun manages to reach proteins with drugs even where this was thought impossible. That is why he and his research group have been allowed to join Oncode Institute. With nine others, he had been selected from 72 applicants to contribute to Oncode Institute's mission: to accelerate breakthroughs…
-
LUMC research improves risk assessment for hereditary breast cancer
Researchers at LUMC have made a breakthrough in understanding PALB2 mutations, an important cause of hereditary breast cancer.
-
700,000 euros for the fight against aggressive breast cancer
To inhibit proteins that contribute to the growth of aggressive cancer cells, that’s the plan of Professor Bob van de Water and his team. They will receive over 700,000 euros from the KWF Dutch Cancer Society for their research. Researcher Maaike Vreeswijk and pathologist Danielle Cohen are affiliated…
-
LUMC researchers use viruses to fight prostate cancer
Modified viruses can both kill cancer cells and activate the immune system. This is what an LUMC team discovered while researching a new prostate cancer therapy.
-
‘Cancer treatment should be a six-week life event’
When internist Christian Blank made his very first discovery, his field of immunotherapy was the underdog of cancer research. Now, over 20 years later, Blank has been appointed Professor By Special Appointment of Internal Medicine for his clinical research into immunotherapy and will give his inaugural…
-
Promising new technique to treat cancer receives NWO grant
Biological chemist Nathaniel Martin and his team received an NWO grant to examine how blocking a specific enzyme in our body, NNMT, could be helpful in the treatment of some cancers. Trials with mice have been promising, and together with the Netherlands Cancer Institute, Martin wants to take the next…
-
Is a cancer pill a matter of time?
A cancer pill, preferably without severe side effects, is something we’d all welcome. Is it a matter of time before such a pill is a reality? We put this question to three Leiden researchers and asked how they themselves are contributing to new cancer treatments.
-
3D-printed mini-tumours: a leap forward in improving cancer immunotherapy
Leiden researchers have developed a groundbreaking model to advance cancer immunotherapy. Using a 3D printer, they create mini-tumors within an environment that closely mimics human tissue. They have also developed a method to monitor real-time interactions of these mini-tumours with immune cells during…
-
More attention needs to be paid to prevention in the fight against cancer
On 11 November Professor of Gastroenterology and Hepatology, Monique van Leerdam will deliver her inaugural lecture entitled, ‘Aiming for Prevention’. Van Leerdam, who specialises in hereditary tumours, was appointed professor in July 2020. In her inaugural lecture she will discuss the importance of…
-
Cancer patients want a doctor who shows empathy and doesn’t make vague promises
Patients with incurable cancer want their oncologist to be clear but to show empathy too. They find hard and vague communication harmful. These are the results of a study by psychologists from Leiden that has been published in the American journal Cancer.